Table 3 Post-transplantation outcomes
Overall (N = 112) | Bridge-ECMO group (n = 27) | Non-bridge-ECMO group (n = 85) | p | |
|---|---|---|---|---|
Immediate complicationsa, n (%) | 48 (42.9%) | 15 (55.6%) | 33 (38.8%) | 0.191 |
Post operation bleeding | 16 (33.3%) | 7 (46.7%) | 9 (27.3%) | 0.322 |
Reoperation | 14 | 6 | 8 | |
Conservative management | 2 | 1 | 1 | |
Infection | 17 (35.4%) | 4 (26.7%) | 13 (39.4%) | 0.597 |
Airway complication | 4 (8.3%) | 2 (13.3%) | 2 (6.1%) | 0.778 |
Total ICU length of stay, day | 13.0 [6.0–31.0] | 33.0 [23.0–43.5] | 9.0 [6.0–16.0] | < 0.001 |
Time interval between transplantation and discharge, day | 39.0 [26.5–67.0] | 46.0 [38.5–68.5] | 35.0 [25.0–67.0] | 0.030 |
Hospital mortality, n (%) | 18 (16.4%) | 7 (25.9%) | 11 (13.3%) | 0.212 |
Function status at discharge, n (%) | 0.295 | |||
Fully independent | 38 (33.9%) | 10 (37.0%) | 28 (32.9%) | |
Partially dependent | 49 (43.8%) | 8 (29.6%) | 41 (48.2%) | |
Fully dependent | 5 (4.5%) | 2 (7.4%) | 3 (3.5%) | |
Tracheostomy at discharge, n (%) | 5 (4.5%) | 1 (3.7%) | 4 (4.7%) | 0.703 |
Final destination, n (%) | 0.405 | |||
Home | 85 (75.9%) | 19 (70.4%) | 66 (77.6%) | |
Other hospital | 7 (6.2%) | 1 (3.7%) | 6 (7.1%) | |
Developed co-morbidityb, n (%) | ||||
Diabetes mellitus | 24 (27.0%) | 5 (27.8%) | 19 (26.8%) | 1.000 |
Hypertension | 16 (18.0%) | 3 (16.7%) | 13 (18.3%) | 1.000 |
PTLD | 1 (1.1%) | 0 (0.0%) | 1 (1.4%) | 1.000 |
Cancer | 1 (1.1%) | 0 (0.0%) | 1 (1.4%) | 1.000 |
CKD with hemodialysis | 3 (2.7%) | 0 (0.0%) | 3 (3.5%) | 0.433 |
6 months mortality, n (%) | 27 (24.1%) | 9 (33.3%) | 18 (21.2%) | 0.304 |